Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
about
Nutraceuticals in Parkinson's DiseasePlant-derived neuroprotective agents in Parkinson's diseaseResveratrol: A Focus on Several Neurodegenerative DiseasesProtective effects and mechanisms of sirtuins in the nervous systemSIRT1 and SIRT2: emerging targets in neurodegenerationParkinson's disease as a result of agingAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemEndoplasmic reticulum stress-induced cell death in dopaminergic cells: effect of resveratrolThe 1-Tosylpentan-3-one Protects against 6-Hydroxydopamine-Induced NeurotoxicityNeuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease.Inhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells.Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.An improved highly sensitive method to determine low oxyresveratrol concentrations in rat plasma and its pharmacokinetic application.Oxyresveratrol from Mulberry as a dihydrate.Oxyresveratrol: Structural Modification and Evaluation of Biological Activities.Microemulsion-based oxyresveratrol for topical treatment of herpes simplex virus (HSV) infection: physicochemical properties and efficacy in cutaneous HSV-1 infection in miceAerobic endurance capacity affects spatial memory and SIRT1 is a potent modulator of 8-oxoguanine repair.Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases.Sirtuins and Their Roles in Brain Aging and Neurodegenerative DisordersBrain activation of SIRT1: role in neuropathology.Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.Sirtuins: from metabolic regulation to brain aging.Resveratrol Protects from Toxin-Induced Parkinsonism: Plethora of Proofs Hitherto Petty Translational Value.Sirtuins as modifiers of Parkinson's disease pathology.Oxyresveratrol suppresses lipopolysaccharide-induced inflammatory responses in murine macrophages.Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.SIRT1 deficiency attenuates MPP+-induced apoptosis in dopaminergic cells.Resveratrol inhibits proliferation and promotes apoptosis of neuroblastoma cells: role of sirtuin 1.GPA protects the nigrostriatal dopamine system by enhancing mitochondrial functionCaloric Restriction and the Nutrient-Sensing PGC-1α in Mitochondrial Homeostasis: New Perspectives in Neurodegeneration.Oxyresveratrol Supplementation to C57bl/6 Mice Fed with a High-Fat Diet Ameliorates Obesity-Associated Symptoms.The protective effects of oxyresveratrol imine derivative against hydrogen peroxide-induced cell death in PC12 cells.Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism.Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3.Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.Plant-Derived Natural Products for Parkinson's Disease Therapy.Phenolic Compounds Characteristic of the Mediterranean Diet in Mitigating Microglia-Mediated Neuroinflammation
P2860
Q26752769-53A8642A-4C5B-476B-8B53-7A7FAC23792AQ26795546-FDE991DA-C24B-462E-BCE1-09E4B6F65452Q26800952-8CE883F1-BD79-440C-B27F-EC368F00A229Q26825585-29936826-4848-48D5-B630-E292B43D3F49Q26864929-C4F087CE-90D0-4BDF-98CC-DAD989F62A60Q28084395-984BEB89-5B50-41CC-A675-8A463B2190C0Q28389419-02A0CB9B-1C8F-466A-B8B4-4B16D7D34129Q28573492-D200AD9D-97A6-44F9-8AFD-CE2A4BADD53FQ32176923-454BAD5F-61F9-4A02-B1AC-4F448660E23DQ33625539-2F0FDCA4-BA75-41DC-96D7-835FCF572D1CQ33674608-0F9402A4-ED24-43C0-A080-A85189BB5FA0Q34460675-1AF5E022-721E-44C9-954E-E241ECD34D26Q35064761-8EAB1F38-E555-4357-8858-6F9E116C6F13Q35934500-19165765-AD4F-48A8-93D8-8A272ED844D0Q35996799-3216FFA2-1110-40E5-B182-41284C57309EQ36442154-88B85919-42C2-4F46-B91E-F1E4070EDA2BQ37375923-71532D68-DC11-47D9-8706-2EDA6D09A011Q37689874-A03B0AEB-9542-4DC9-A19E-078AE09E42B3Q37710177-BB31DD2A-3CC5-4FDE-9300-1BC01322C33AQ38101493-B67B82AC-98BE-473D-9710-573AFD22436FQ38120532-EA1EBBCA-1A37-4E01-BC65-2D3372D83225Q38124259-5E34AA75-C0D9-49DD-B6C2-8042319E098EQ38359538-B54B7A00-F1F9-4FB4-A50F-6A95C4AB6ACEQ38893382-66209428-6875-4486-B03F-7F7122AB4AD9Q38937717-F596DAC2-2DC0-4FCC-8A39-46CD5B61A1ACQ39460847-E6087E8F-809A-44FD-A64B-A8045FB9FDD7Q39624115-CAFED73C-C312-4D64-B82F-F4AB4AA2A645Q39640335-9BB8D53A-4D18-4549-BD3E-B6F30306D0B5Q39765110-C55F567C-912D-43F0-8351-8283A2ECE65FQ41885050-43D23A7A-4EDE-4B6F-9070-481375EFEF33Q42319075-AB2A482A-6579-4168-9059-5383B287B39AQ42713453-4FEC9C48-C057-4E8F-A046-A26B13079E94Q47266104-6268FF7A-6176-4910-A925-59A1E0D839DAQ48680527-D0AF64EE-7A4E-4CAB-8B0A-A002CF097831Q50910086-64F57036-4C16-40AD-AD22-FEAF5C8B483EQ51800931-AB0D1140-FBD3-4328-937D-D94BE9808B18Q58572097-49E1052E-9DB7-491C-92E0-FB05FF9983A0
P2860
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
@en
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
@nl
type
label
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
@en
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
@nl
prefLabel
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
@en
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
@nl
P50
P1476
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
@en
P2093
Jianfei Chao
Man-Shan Yu
P304
P356
10.1016/J.FREERADBIOMED.2008.07.002
P577
2008-07-16T00:00:00Z